IL37 and colitis: Moreover, administration of exogenous IL-23 in RAG mice reconstituted with naïve CD4+ T-cells caused a more severe colitis that was associated with enhanced production of IL-6 and IL-17 and preventable by treatment of mice with a blocking IL-6 or IL-17 antibody.